HIGHLIGHTS
- who: USER from the Health Center Santa Maria de Benquerencia Toledo have published the Article: Characteristics and Vaccine Booster Effectiveness in Covid-19, in the Journal: (JOURNAL) of February/28,/2022
- what: This approach has the potential for variant misclassification.
- how: In the study the same type of mRNA_vaccines was used in both the primary and booster series in most of the population but the booster dose of mRNA1273 was half the dose used in the primary series.
SUMMARY
In the heterologous regimen in which Vaxzevria (Oxford / AstraZeneca) is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.